Matinas BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(9.99%)
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Matkovits Theresa
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Hoover Thomas
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Kucinski Keith A
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Liu Hui
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Jabbour Jerome D
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Ferguson James J. III
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Ende Eric J
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Corzo Kathryn Penkus
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director WIKLER MATTHEW
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director CONRAD HERBERT J
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Scibetta James S
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Giordano Natasha
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
No Data
No Data